Ultragenyx
Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.
About
Technology stack
detected 2026-06-10No comments yet. Be the first to share your take.
What does Ultragenyx do?
Ultragenyx is a biopharmaceutical company dedicated to developing and delivering transformative treatments for rare and ultrarare genetic diseases where no current options exist. They explore various drug modalities to create the best treatment strategy for each genetic disease they study, serving patients globally. The company is committed to advancing innovative medicines and has a robust pipeline of therapies in development.
How much funding has Ultragenyx raised?
Ultragenyx has raised a total of $100M in funding. The most recent round on record is IPO.
Where is Ultragenyx headquartered?
Ultragenyx is headquartered in Novato, United States.
When was Ultragenyx founded?
Ultragenyx was founded in 2010.
What industry does Ultragenyx operate in?
Ultragenyx operates in Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials, Genomics.
How many employees does Ultragenyx have?
Ultragenyx has approximately 1498 people on record.